ICAM1 and neoplasm: Functional assays have revealed that endocan inhibits lymphocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) interaction [36], an important step in the firm adhesion of leukocytes to the endothelium, and thus may regulate the migration of leukocyte into tumor tissues.